Who
Sandra Boenisch
PFO & Treasurer
Company insider
Files Form 4 as: PFO & Treasurer, Anavex Life Sciences; Chief Financial Officer, Destiny Media Technologies.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $4.4M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 22 Sep 2016
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jan 2026filed 9 Jan 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 6 Jan 2026filed 9 Jan 2026 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 2 Oct 2025filed 3 Oct 2025 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 20 Aug 2025filed 22 Aug 2025 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 28 Apr 2025filed 30 Apr 2025 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 19 Dec 2024filed 23 Dec 2024 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 19 Nov 2024filed 6 Dec 2024 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Jan 2024filed 12 Jan 2024 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Aug 2021filed 4 Aug 2021 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 29 Jun 2021filed 1 Jul 2021 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 29 Jun 2021filed 1 Jul 2021 | AVXL Anavex Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —106,696 at $0.00 | filing |
News
Kaplan Fox Reminds Investors of Anavex Life Sciences Corp. (NASDAQ: ...AVXL · pr-inside.com · 22 Oct 2026Kaplan Fox Encourages Anavex Life Sciences Corp. (NASDAQ: AVXL) Investors ...AVXL · pr-inside.com · 14 Oct 2026ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXLAVXL · wallstreet-online.de · 13 Oct 2026
0 headlines in the last 90 days name Sandra Boenisch; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.